Polycystic Ovary Syndrome: A Contemporary Clinical Approach
- 1 October 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 27 (36), 3812-3820
- https://doi.org/10.2174/1381612827666210119104721
Abstract
Polycystic ovary syndrome (PCOS) is a frequent endocrine disease in women during the reproductive period. It is considered a complex metabolic disorder with long-term metabolic, as well as reproductive consequences. Main pathophysiological pathways are related to the increased androgen levels and insulin resistance. Nowadays, genetic origins of PCOS are acknowledged, with numerous genes involved in the pathogenesis of hyperandrogenemia, insulin resistance, inflammation, and disturbed folliculogenesis. Rotterdam diagnostic criteria are most widely accepted and four PCOS phenotypes have been recognized. Metabolic abnormalities are more common in phenotypes 1 and 2. Women with classic PCOS are more obese and typically have the central type of obesity, more prevalently displaying dyslipidemia, insulin resistance, and metabolic syndrome that could be associated with an increased risk of cardiovascular complications during life. Heterogeneity of phenotypes demands an individualized approach in the treatment of women with PCOS. Metabolic therapies involve a lifestyle intervention followed by the introduction of insulin sensitizers including metformin and inositols, glucagon-like peptide 1 receptor agonists (GLP-1 RA), as recently sodium-glucose cotransporter-2 (SGLT2) inhibitors. The addition of an insulin sensitizer to the standard infertility therapy such as clomiphene citrate improves ovulation and pregnancy rates. Our current review analyzes the contemporary knowledge of PCOS etiology and etiopathogenesis, its cardiometabolic risks and their outcomes, as well as therapeutic advances for women with PCOS.Keywords
Funding Information
- Serbian Ministry of Education, Science and Technological Development (451-03-68/2020-14/200007)
This publication has 68 references indexed in Scilit:
- Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOSClinical Endocrinology, 2013
- Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysisHuman Reproduction Update, 2011
- Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysisClinical Endocrinology, 2010
- Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transferFertility and Sterility, 2009
- Visually scoring hirsutismHuman Reproduction Update, 2009
- Alanine Aminotransferase, γ-Glutamyltransferase, and Incident DiabetesDiabetes Care, 2009
- Association of CYP3A7*1C and Serum Dehydroepiandrosterone Sulfate Levels in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2008
- The reproductive phenotype in polycystic ovary syndromeNature Clinical Practice Endocrinology & Metabolism, 2007
- Pathophysiology and types of dyslipidemia in PCOSTrends in Endocrinology & Metabolism, 2007
- Obesity and polycystic ovary syndromeClinical Endocrinology, 2006